183 related articles for article (PubMed ID: 18031247)
21. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling.
Gosu V; Basith S; Kwon OP; Choi S
Molecules; 2012 Nov; 17(11):13503-29. PubMed ID: 23151919
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
Panter G; Kuznik A; Jerala R
Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
[TBL] [Abstract][Full Text] [Related]
24. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
Conroy H; Marshall NA; Mills KH
Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic and therapeutic implications of toll-like receptor ligands.
Hedayat M; Takeda K; Rezaei N
Med Res Rev; 2012 Mar; 32(2):294-325. PubMed ID: 22383179
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptor and RIG-I-like receptor signaling.
Kawai T; Akira S
Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
[TBL] [Abstract][Full Text] [Related]
27. Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women.
Nazli A; Yao XD; Smieja M; Rosenthal KL; Ashkar AA; Kaushic C
Antiviral Res; 2009 Feb; 81(2):103-12. PubMed ID: 19013198
[TBL] [Abstract][Full Text] [Related]
28. Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies.
Spaner DE; Foley R; Galipeau J; Bramson J
Oncogene; 2008 Jan; 27(2):208-17. PubMed ID: 18176602
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptors and agonist responses in the developing fetal sheep lung.
Hillman NH; Moss TJ; Nitsos I; Kramer BW; Bachurski CJ; Ikegami M; Jobe AH; Kallapur SG
Pediatr Res; 2008 Apr; 63(4):388-93. PubMed ID: 18356744
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
Lester RT; Yao XD; Ball TB; McKinnon LR; Kaul R; Wachihi C; Jaoko W; Plummer FA; Rosenthal KL
AIDS; 2008 Mar; 22(6):685-94. PubMed ID: 18356597
[TBL] [Abstract][Full Text] [Related]
31. Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
Lai CY; Su YW; Lin KI; Hsu LC; Chuang TH
J Immunol Res; 2017; 2017():7807313. PubMed ID: 28894754
[TBL] [Abstract][Full Text] [Related]
32. Ligand specificities of Toll-like receptors in fish: indications from infection studies.
Pietretti D; Wiegertjes GF
Dev Comp Immunol; 2014 Apr; 43(2):205-22. PubMed ID: 23981328
[TBL] [Abstract][Full Text] [Related]
33. The antiviral activity of Toll-like receptor 7 and 7/8 agonists.
Miller RL; Meng TC; Tomai MA
Drug News Perspect; 2008 Mar; 21(2):69-87. PubMed ID: 18389099
[TBL] [Abstract][Full Text] [Related]
34. Expression and function of toll-like receptors at the maternal-fetal interface.
Koga K; Mor G
Reprod Sci; 2008 Apr; 15(3):231-42. PubMed ID: 18421019
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.
Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243
[TBL] [Abstract][Full Text] [Related]
36. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways.
Ittah M; Miceli-Richard C; Gottenberg JE; Sellam J; Eid P; Lebon P; Pallier C; Lepajolec C; Mariette X
Eur J Immunol; 2008 Apr; 38(4):1058-64. PubMed ID: 18350548
[TBL] [Abstract][Full Text] [Related]
37. Immunodeficiency: UNC-93B gets a toll call.
Conley ME
Trends Immunol; 2007 Mar; 28(3):99-101. PubMed ID: 17240194
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptors in tonsillar epithelial cells.
Lange MJ; Lasiter JC; Misfeldt ML
Int J Pediatr Otorhinolaryngol; 2009 Apr; 73(4):613-21. PubMed ID: 19167100
[TBL] [Abstract][Full Text] [Related]
39. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
Lahiri A; Das P; Chakravortty D
Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptors and innate immunity.
Kumar H; Kawai T; Akira S
Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
